Denis Larsimont Selected Research

Denis Larsimont Research Topics

Disease

62	Breast Neoplasms (Breast Cancer) 08/2021 - 05/2002
57	Neoplasms (Cancer) 08/2021 - 05/2002
9	Neoplasm Metastasis (Metastasis) 06/2020 - 10/2008
5	Colorectal Neoplasms (Colorectal Cancer) 08/2020 - 12/2005
3	Carcinoma (Carcinomatosis) 01/2021 - 10/2016
3	Pathologic Complete Response 01/2018 - 10/2013
3	Tertiary Lymphoid Structures 01/2018 - 01/2017
2	Triple Negative Breast Neoplasms 01/2020 - 01/2016
2	Papillary Thyroid Cancer 01/2019 - 04/2015
2	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2017 - 08/2010
2	Squamous Cell Carcinoma of Head and Neck 11/2016 - 10/2016
2	Disease Progression 01/2016 - 07/2015
1	Mucinous Adenocarcinoma (Mucinous Carcinoma) 01/2021
1	Stomach Neoplasms (Stomach Cancer) 01/2021
1	Ductal Carcinoma 01/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Margins of Excision 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 02/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2019
1	Ovarian Neoplasms (Ovarian Cancer) 12/2018
1	Cicatrix (Scar) 02/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2017
1	Mesothelioma 11/2017
1	Melanoma (Melanoma, Malignant) 11/2017
1	Brain Neoplasms (Brain Tumor) 11/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2017
1	Extranodal Extension 09/2017

Drug/Important Bio-Agent (IBA)

14	Estrogen ReceptorsIBA 06/2020 - 03/2003
10	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2008
9	ParaffinIBA 08/2017 - 07/2002
8	Phenobarbital (Luminal)FDA Link 08/2021 - 07/2005
8	Indocyanine Green (Cardio-Green)FDA LinkGeneric 01/2021 - 01/2016
8	AnthracyclinesIBA 08/2017 - 05/2002
6	Hormones (Hormone)IBA 01/2019 - 10/2005
6	Proteins (Proteins, Gene)FDA Link 01/2019 - 07/2002
5	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2005
5	RNA (Ribonucleic Acid)IBA 01/2020 - 01/2013
5	Trastuzumab (Herceptin)FDA Link 01/2018 - 10/2006
5	Tamoxifen FDA LinkGeneric 02/2016 - 12/2004
5	Type II DNA Topoisomerases (Topoisomerase II)IBA 10/2013 - 10/2004
4	Eosine Yellowish-(YS) (Eosin)IBA 01/2021 - 01/2017
4	Hematoxylin (Haematoxylon)IBA 01/2021 - 01/2017
4	Progesterone Receptors (Progesterone Receptor)IBA 01/2020 - 12/2004
4	Formaldehyde (Formol)FDA Link 08/2017 - 03/2008
4	Messenger RNA (mRNA)IBA 10/2013 - 12/2006
4	Docetaxel (Taxotere)FDA Link 05/2012 - 12/2002
3	human ERBB2 proteinIBA 01/2018 - 12/2009
3	ErbB Receptors (EGF Receptor)IBA 01/2016 - 12/2005
3	Epirubicin (Ellence)FDA LinkGeneric 10/2013 - 05/2002
3	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2012 - 10/2004
3	trioctyl phosphine oxide (TOPO)IBA 12/2008 - 05/2002
2	Glucose (Dextrose)FDA LinkGeneric 05/2021 - 08/2017
2	Letrozole (Femara)FDA LinkGeneric 01/2021 - 02/2016
2	Aromatase InhibitorsIBA 01/2021 - 06/2009
2	Tumor Biomarkers (Tumor Markers)IBA 01/2021 - 06/2009
2	MucinsIBA 01/2021 - 01/2019
2	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 01/2019
2	CytokinesIBA 01/2019 - 07/2013
2	ChemokinesIBA 01/2019 - 07/2013
2	AntigensIBA 01/2018 - 07/2002
2	Estrogens (Estrogen)FDA Link 01/2018 - 06/2009
2	Biological ProductsIBA 11/2016 - 07/2015
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2016 - 08/2009
2	Peptide Hydrolases (Proteases)FDA Link 08/2010 - 12/2006
2	tau Proteins (tau Protein)IBA 07/2008 - 12/2002
2	TubulinIBA 07/2008 - 12/2002
1	durvalumabIBA 08/2021
1	Adenosine (Adenocard)FDA LinkGeneric 08/2021
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2021
1	Circulating Tumor DNAIBA 01/2021
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2021
1	Denosumab FDA Link 12/2020
1	Indicators and Reagents (Reagents)IBA 06/2020
1	SirtuinsIBA 02/2020
1	atezolizumabIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	130-nm albumin-bound paclitaxelIBA 01/2020
1	Progesterone FDA LinkGeneric 01/2019
1	Pyruvate CarboxylaseIBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 09/2018
1	Cisplatin (Platino)FDA LinkGeneric 09/2018
1	Cyclin D1IBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	AutoantibodiesIBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2018
1	Differentiation AntigensIBA 01/2018
1	AntibodiesIBA 01/2018
1	Expectorants (Mucolytics)IBA 08/2017
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2017
1	Pharmaceutical PreparationsIBA 08/2017
1	hydrogen sulfite (bisulfite)IBA 08/2017

Therapy/Procedure

15	Therapeutics 02/2020 - 05/2002
9	Drug Therapy (Chemotherapy) 08/2021 - 07/2008
4	Adjuvant Chemotherapy 08/2021 - 08/2014
4	Immunotherapy 01/2021 - 11/2017
4	Neoadjuvant Therapy 02/2018 - 01/2013
2	Radiotherapy 08/2021 - 02/2020
2	Cytoreduction Surgical Procedures 02/2018 - 12/2016
1	Segmental Mastectomy (Lumpectomy) 01/2021
1	Intravenous Injections 08/2020